SG11202008182TA - Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor - Google Patents
Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses thereforInfo
- Publication number
- SG11202008182TA SG11202008182TA SG11202008182TA SG11202008182TA SG11202008182TA SG 11202008182T A SG11202008182T A SG 11202008182TA SG 11202008182T A SG11202008182T A SG 11202008182TA SG 11202008182T A SG11202008182T A SG 11202008182TA SG 11202008182T A SG11202008182T A SG 11202008182TA
- Authority
- SG
- Singapore
- Prior art keywords
- aav
- vectors
- associated virus
- uses therefor
- novel adeno
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862635964P | 2018-02-27 | 2018-02-27 | |
| US201862667585P | 2018-05-29 | 2018-05-29 | |
| US201862677471P | 2018-05-29 | 2018-05-29 | |
| US201862703670P | 2018-07-26 | 2018-07-26 | |
| US201862722382P | 2018-08-24 | 2018-08-24 | |
| PCT/US2019/019804 WO2019168961A1 (en) | 2018-02-27 | 2019-02-27 | Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202008182TA true SG11202008182TA (en) | 2020-09-29 |
Family
ID=67805569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202008182TA SG11202008182TA (en) | 2018-02-27 | 2019-02-27 | Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20200407750A1 (en) |
| EP (1) | EP3758724A4 (en) |
| JP (3) | JP2021516046A (en) |
| KR (1) | KR20210010434A (en) |
| CN (1) | CN112352050A (en) |
| AU (1) | AU2019227726A1 (en) |
| BR (1) | BR112020017348A2 (en) |
| CA (1) | CA3091806A1 (en) |
| CL (2) | CL2020002200A1 (en) |
| IL (1) | IL276859A (en) |
| MX (1) | MX2020008933A (en) |
| SG (1) | SG11202008182TA (en) |
| WO (1) | WO2019168961A1 (en) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017058892A2 (en) | 2015-09-28 | 2017-04-06 | The University Of North Carolina At Chapel Hill | Methods and compositions for antibody-evading virus vectors |
| BR112020020266A2 (en) | 2018-04-03 | 2021-01-19 | Stridebio, Inc. | VIRUSES WITH ANTIBODY EVASION |
| EP3773743A1 (en) | 2018-04-03 | 2021-02-17 | Stridebio, Inc. | Virus vectors for targeting ophthalmic tissues |
| MX2020010466A (en) | 2018-04-03 | 2021-01-08 | Antibody-evading virus vectors. | |
| KR20220011616A (en) | 2019-03-21 | 2022-01-28 | 스트라이드바이오 인코포레이티드 | Recombinant adeno-associated viral vectors |
| JP2022550435A (en) | 2019-10-04 | 2022-12-01 | ウルトラジェニックス ファーマシューティカル インコーポレイテッド | Methods for improved therapeutic use of recombinant AAV |
| AU2020367532A1 (en) | 2019-10-17 | 2022-05-12 | Ginkgo Bioworks, Inc. | Adeno-associated viral vectors for treatment of Niemann-Pick disease type C |
| JP2022552892A (en) * | 2019-10-21 | 2022-12-20 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | AAV3B mutants with improved production yields and liver tropism |
| CA3222852A1 (en) * | 2020-01-03 | 2021-07-08 | Sarepta Therapeutics, Inc. | Methods for analyzing aav capsid proteins |
| CN115151648A (en) * | 2020-02-14 | 2022-10-04 | 阿尔特拉吉尼克斯制药公司 | Gene therapy for the treatment of CDKL5 deficient disorders |
| US20230129893A1 (en) | 2020-03-31 | 2023-04-27 | Ultragenyx Pharmaceutical Inc. | Gene therapy for treating propionic acidemia |
| JP2023531451A (en) | 2020-06-17 | 2023-07-24 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | Compositions and methods for treatment of gene therapy patients |
| MX2023000658A (en) | 2020-07-13 | 2023-02-23 | Univ Pennsylvania | Compositions useful for treatment of charcot-marie-tooth disease. |
| KR20230068444A (en) | 2020-08-19 | 2023-05-17 | 사렙타 쎄러퓨틱스 인코퍼레이티드 | Adeno-associated viral vectors for the treatment of Rett syndrome |
| EP4229186A1 (en) * | 2020-10-18 | 2023-08-23 | The Trustees of The University of Pennsylvania | Improved adeno-associated virus (aav) vector and uses therefor |
| AU2021369793A1 (en) * | 2020-10-29 | 2023-06-08 | The Trustees Of The University Of Pennsylvania | Aav capsids and compositions containing same |
| TW202237850A (en) | 2020-12-01 | 2022-10-01 | 賓州大學委員會 | Novel compositions with tissue-specific targeting motifs and compositions containing same |
| AU2022214429A1 (en) | 2021-02-01 | 2023-09-14 | Regenxbio Inc. | Gene therapy for neuronal ceroid lipofuscinoses |
| WO2022221276A1 (en) | 2021-04-12 | 2022-10-20 | The Trustees Of The University Of Pennsylvania | Compositions useful for treating spinal and bulbar muscular atrophy (sbma) |
| US20240207452A1 (en) | 2021-04-23 | 2024-06-27 | The Trustees Of The University Of Pennsylvania | Novel compositions with brain-specific targeting motifs and compositions containing same |
| IL313832A (en) * | 2021-12-28 | 2024-08-01 | Chengdu Origen Biotechnology Co Ltd | Modified aav capsid protein and use thereof |
| TW202338086A (en) | 2022-01-10 | 2023-10-01 | 賓州大學委員會 | Compositions useful in treatment of metachromatic leukodystrophy |
| AR128239A1 (en) | 2022-01-10 | 2024-04-10 | Univ Pennsylvania | COMPOSITIONS AND USEFUL METHODS FOR THE TREATMENT OF DISORDERS MEDIATED BY C9ORF72 |
| WO2023147304A1 (en) | 2022-01-25 | 2023-08-03 | The Trustees Of The University Of Pennsylvania | Aav capsids for improved heart transduction and detargeting of liver |
| TW202342740A (en) | 2022-03-07 | 2023-11-01 | 美商奧崔基尼克斯製藥公司 | Modified batch aav production systems and methods |
| WO2023196892A1 (en) | 2022-04-06 | 2023-10-12 | The Trustees Of The University Of Pennsylvania | Passive immunization with anti- aav neutralizing antibodies to prevent off-target transduction of intrathecally delivered aav vectors |
| CN115011601B (en) * | 2022-06-27 | 2023-07-21 | 山东大学齐鲁医院 | shRNA (short hairpin ribonucleic acid) interfering with JUND expression, recombinant adeno-associated virus vector and application thereof |
| WO2024015966A2 (en) * | 2022-07-15 | 2024-01-18 | The Trustees Of The University Of Pennsylvania | Recombinant aav having aav clade d and clade e capsids and compositions containing same |
| WO2024130070A2 (en) | 2022-12-17 | 2024-06-20 | The Trustees Of The University Of Pennsylvania | Recombinant aav capsids with cardiac- and skeletal muscle- specific targeting motifs and uses thereof |
| WO2024130067A2 (en) | 2022-12-17 | 2024-06-20 | The Trustees Of The University Of Pennsylvania | Recombinant aav mutant vectors with cardiac and skeletal muscle-specific targeting motifs and compositions containing same |
| WO2024138129A2 (en) * | 2022-12-23 | 2024-06-27 | Spark Therapeutics, Inc. | Adeno-associated virus formulations |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2648241T3 (en) * | 2003-09-30 | 2017-12-29 | The Trustees Of The University Of Pennsylvania | Adeno-associated virus clades (AAV), sequences, vectors containing the same, and uses thereof |
| US8999678B2 (en) * | 2005-04-07 | 2015-04-07 | The Trustees Of The University Of Pennsylvania | Method of increasing the function of an AAV vector |
| MY172457A (en) * | 2012-04-18 | 2019-11-26 | Childrens Hospital Philadelphia | Composition and methods for highly efficient gene transfer using aav capsid variants |
| EP3024498B1 (en) * | 2013-07-22 | 2019-12-04 | The Children's Hospital of Philadelphia | Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues |
| US11015173B2 (en) * | 2015-12-11 | 2021-05-25 | The Trustees Of The University Of Pennsylvania | Scalable purification method for AAV1 |
| WO2017180854A1 (en) * | 2016-04-15 | 2017-10-19 | The Trustees Of The University Of Pennsylvania | Novel aav8 mutant capsids and compositions containing same |
| CN118688363A (en) * | 2016-08-15 | 2024-09-24 | 建新公司 | Methods of detecting AAV |
| LT3589730T (en) * | 2017-02-28 | 2024-03-12 | The Trustees Of The University Of Pennsylvania | Adeno-associated virus (aav) clade f vector and uses therefor |
-
2019
- 2019-02-27 EP EP19760264.2A patent/EP3758724A4/en active Pending
- 2019-02-27 CN CN201980028806.2A patent/CN112352050A/en active Pending
- 2019-02-27 CA CA3091806A patent/CA3091806A1/en active Pending
- 2019-02-27 MX MX2020008933A patent/MX2020008933A/en unknown
- 2019-02-27 WO PCT/US2019/019804 patent/WO2019168961A1/en unknown
- 2019-02-27 SG SG11202008182TA patent/SG11202008182TA/en unknown
- 2019-02-27 JP JP2020545160A patent/JP2021516046A/en active Pending
- 2019-02-27 US US16/975,541 patent/US20200407750A1/en active Pending
- 2019-02-27 AU AU2019227726A patent/AU2019227726A1/en active Pending
- 2019-02-27 BR BR112020017348-7A patent/BR112020017348A2/en unknown
- 2019-02-27 KR KR1020207027457A patent/KR20210010434A/en active Search and Examination
-
2020
- 2020-08-23 IL IL276859A patent/IL276859A/en unknown
- 2020-08-26 CL CL2020002200A patent/CL2020002200A1/en unknown
-
2022
- 2022-12-26 CL CL2022003757A patent/CL2022003757A1/en unknown
-
2023
- 2023-08-14 JP JP2023131761A patent/JP2023159235A/en active Pending
-
2024
- 2024-01-18 JP JP2024005924A patent/JP2024041967A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL276859A (en) | 2020-10-29 |
| MX2020008933A (en) | 2021-01-15 |
| CL2020002200A1 (en) | 2021-01-29 |
| CL2022003757A1 (en) | 2023-05-19 |
| EP3758724A4 (en) | 2022-07-06 |
| JP2023159235A (en) | 2023-10-31 |
| JP2024041967A (en) | 2024-03-27 |
| AU2019227726A1 (en) | 2020-09-10 |
| JP2021516046A (en) | 2021-07-01 |
| BR112020017348A2 (en) | 2020-12-29 |
| WO2019168961A1 (en) | 2019-09-06 |
| US20200407750A1 (en) | 2020-12-31 |
| CN112352050A (en) | 2021-02-09 |
| KR20210010434A (en) | 2021-01-27 |
| EP3758724A1 (en) | 2021-01-06 |
| CA3091806A1 (en) | 2019-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL276859A (en) | Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor | |
| IL276860A (en) | Novel adeno-associated virus (aav) vectors, aav vectors having reduced capsid deamidation and uses therefor | |
| IL286464A (en) | Recombinant adeno-associated virus vectors | |
| IL286911A (en) | Recombinant adeno-associated viruses and uses thereof | |
| ZA201905407B (en) | Adeno-associated virus (aav) clade f vector and uses therefor | |
| IL282885A (en) | Aav viral vectors and uses thereof | |
| IL263801A (en) | Novel adeno-associated virus capsid proteins | |
| ZA201801657B (en) | Adeno-associated virus factor viii vectors, associated viral particles and therapeutic formulations comprising the same | |
| IL286831A (en) | Adeno-associated virus with engineered capsid | |
| EP3575398A4 (en) | Mutant of adeno-associated virus (aav) capsid protein | |
| EP3943503A4 (en) | Adeno-associated virus having variant capsid protein and use thereof | |
| EP4061427A4 (en) | Adeno-associated viral vector variants | |
| IL287214A (en) | Adeno-associated virus vector formulations and methods | |
| IL286725A (en) | Engineered adeno-associated (aav) vectors for transgene expression | |
| EP3790979A4 (en) | Adeno-associated virus (aav) delivery of anti-fam19a5 antibodies | |
| EP4110792A4 (en) | Adeno-associated virus capsid polypeptides and vectors | |
| IL287614A (en) | Modified adeno-associated virus (aav) particles for gene therapy | |
| SG11201704919SA (en) | Methods of purifying adeno-associated virus (aav) and/or recombinant adeno-associated virus (raav) | |
| IL304688A (en) | Adeno-associated virus (aav) production | |
| SG11202006169PA (en) | Adeno-associated virus (aav) vector having hybrid hgf gene introduced thereto | |
| EP3810635A4 (en) | Aav polynucleotides, polypeptides and virions | |
| AU2019902377A0 (en) | AAV capsid polypeptides and AAV vectors | |
| EP3751000A4 (en) | Improved adeno-associated virus vector | |
| AU2020904687A0 (en) | Adeno-associated virus capsids and vectors | |
| AU2020900529A0 (en) | Adeno-associated virus capsid polypeptides and vectors |